JANX vs PLTR · rev $10.3M vs P/E 584, rev $3.57B
Janux Therapeutics Inc (JANX) versus Palantir Technologies Inc. Class A Common Stock (PLTR) — a side-by-side from cached financials, not a winner call.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
Latest reported JANX revenue for 2026-06-30 was $10.3M. Net income was -$22.0M. JANX currently screens at market cap $1.49B.
Latest reported PLTR revenue for 2026-06-30 was $3.57B. Net income was $1.93B. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
JANX currently screens at market cap $1.49B. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
Not investment advice. Open the JANX and PLTR stock pages for the full models.
Not investment advice.